I just recommended him to a friend
Patient selection should consider contraindications, including personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (boxed warning), and hypersensitivity to semaglutide or any product components
Quick Answer: Semaglutide is self-administered as a once-weekly subcutaneous injection into the abdomen, thigh, or upper arm using either a multi-dose pen (Ozempic) or single-dose pen (Wegovy)
While the compounding facility that we source semaglutide medication from is FDA inspected, compounded medications themselves are are not reviewed by the FDA for safety of efficacy
You do not need to share every detail, just enough that they understand it is a medication side effect, not a hygiene issue
For researchers serious about optimizing their GLP-1 protocols while managing side effects effectively, SeekPeptides offers evidence-based guides, community support from experienced users, and comprehensive protocol databases that address exactly these long-term considerations